Correlation Between Valneva SE and Milestone Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Valneva SE and Milestone Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Milestone Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and Milestone Pharmaceuticals, you can compare the effects of market volatilities on Valneva SE and Milestone Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Milestone Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Milestone Pharmaceuticals.

Diversification Opportunities for Valneva SE and Milestone Pharmaceuticals

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Valneva and Milestone is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Milestone Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Milestone Pharmaceuticals and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Milestone Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Milestone Pharmaceuticals has no effect on the direction of Valneva SE i.e., Valneva SE and Milestone Pharmaceuticals go up and down completely randomly.

Pair Corralation between Valneva SE and Milestone Pharmaceuticals

Given the investment horizon of 90 days Valneva SE ADR is expected to under-perform the Milestone Pharmaceuticals. In addition to that, Valneva SE is 1.12 times more volatile than Milestone Pharmaceuticals. It trades about -0.06 of its total potential returns per unit of risk. Milestone Pharmaceuticals is currently generating about 0.03 per unit of volatility. If you would invest  168.00  in Milestone Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of  16.00  from holding Milestone Pharmaceuticals or generate 9.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Valneva SE ADR  vs.  Milestone Pharmaceuticals

 Performance 
       Timeline  
Valneva SE ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Valneva SE ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Milestone Pharmaceuticals 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Milestone Pharmaceuticals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Milestone Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Valneva SE and Milestone Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Valneva SE and Milestone Pharmaceuticals

The main advantage of trading using opposite Valneva SE and Milestone Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Milestone Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Milestone Pharmaceuticals will offset losses from the drop in Milestone Pharmaceuticals' long position.
The idea behind Valneva SE ADR and Milestone Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Commodity Directory
Find actively traded commodities issued by global exchanges